UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis

Author
Michelle Lai, MD, MPH
Section Editor
Sanjiv Chopra, MD, MACP
Deputy Editor
Kristen M Robson, MD, MBA, FACG

INTRODUCTION

Budd-Chiari syndrome (BCS) is defined as hepatic venous outflow tract obstruction, independent of the level or mechanism of obstruction, provided the obstruction is not due to cardiac disease, pericardial disease, or sinusoidal obstruction syndrome (veno-occlusive disease) [1]. Primary Budd-Chiari syndrome is present when there is obstruction due to a predominantly venous process (thrombosis or phlebitis), whereas secondary Budd-Chiari is present when there is compression or invasion of the hepatic veins and/or the inferior vena cava by a lesion that originates outside of the vein (eg, a malignancy).

This topic will review the epidemiology, clinical manifestations, and diagnosis of Budd-Chiari syndrome. The etiology and treatment of Budd-Chiari syndrome are discussed separately. (See "Etiology of the Budd-Chiari syndrome" and "Budd-Chiari syndrome: Management".)

EPIDEMIOLOGY

Studies suggest that in non-Asian countries, Budd-Chiari syndrome is more common in women and usually presents in the third or fourth decade of life (although it may occur in children or older adults) [2,3]. By contrast, in Asia, there is a slight predominance of men, with a median age of 45 years at presentation. In the non-Asian countries, pure hepatic vein blockage is more common, whereas in Asia, pure inferior vena cava or combined inferior vena cava and hepatic vein blockage predominate [3,4].

In a ten year study of hospital admissions in Italy that included 287 patients with BCS, the incidence rates for males and females were 2.0 and 2.2 per million inhabitants, respectively [5]. The median age was 50 years (interquartile range 36 to 68 years) and 54 percent of patients were female. In another series that included 237 patients who had been treated for BCS at four centers in the United States, the Netherlands, and France, the median age was 35 years (range 13 to 76 years) and 67 percent of patients were female [4]. The location of the outflow obstruction was in the hepatic veins (62 percent), inferior vena cava (7 percent), or both (31 percent), and 34 patients (14 percent) had associated portal vein thrombosis.

CATEGORIZATION

Budd-Chiari syndrome is categorized by disease duration and severity [6,7]:

                     

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2017. | This topic last updated: Aug 02, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49:1729.
  2. Mahmoud AE, Mendoza A, Meshikhes AN, et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM 1996; 89:37.
  3. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis 2008; 28:259.
  4. Darwish Murad S, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39:500.
  5. Ageno W, Dentali F, Pomero F, et al. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost 2017; 117:794.
  6. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004; 350:578.
  7. Ferral H, Behrens G, Lopera J. Budd-Chiari syndrome. AJR Am J Roentgenol 2012; 199:737.
  8. Fickert P, Ramschak H, Kenner L, et al. Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation. Gastroenterology 1996; 111:1670.
  9. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151:167.
  10. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106:1042.
  11. Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 1982; 61:199.
  12. De BK, Sen S, Biswas PK, et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology 2002; 122:897.
  13. Miller WJ, Federle MP, Straub WH, Davis PL. Budd-Chiari syndrome: imaging with pathologic correlation. Abdom Imaging 1993; 18:329.
  14. Millener P, Grant EG, Rose S, et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993; 161:307.
  15. Chawla Y, Kumar S, Dhiman RK, et al. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999; 14:904.
  16. Grant EG, Perrella R, Tessler FN, et al. Budd-Chiari syndrome: the results of duplex and color Doppler imaging. AJR Am J Roentgenol 1989; 152:377.
  17. Gupta S, Barter S, Phillips GW, et al. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut 1987; 28:242.
  18. Soyer P, Rabenandrasana A, Barge J, et al. MRI of Budd-Chiari syndrome. Abdom Imaging 1994; 19:325.
  19. Friedman AC, Ramchandani P, Black M, et al. Magnetic resonance imaging diagnosis of Budd-Chiari syndrome. Gastroenterology 1986; 91:1289.
  20. Lin J, Zhou KR, Chen ZW, et al. Vena cava 3D contrast-enhanced MR venography: a pictorial review. Cardiovasc Intervent Radiol 2005; 28:795.
  21. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 2003; 37:510.
  22. Tang TJ, Batts KP, de Groen PC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001; 35:338.
  23. Dilawari JB, Bambery P, Chawla Y, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994; 73:21.
  24. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 51-1987. Progressive abdominal distention in a 51-year-old woman with polycythemia vera. N Engl J Med 1987; 317:1587.
  25. Powell-Jackson PR, Melia W, Canalese J, et al. Budd-Chiari Syndrome: clinical patterns and therapy. Q J Med 1982; 51:79.
  26. Gupta S, Blumgart LH, Hodgson HJ. Budd-Chiari syndrome: long-term survival and factors affecting mortality. Q J Med 1986; 60:781.
  27. Murphy FB, Steinberg HV, Shires GT 3rd, et al. The Budd-Chiari syndrome: a review. AJR Am J Roentgenol 1986; 147:9.
  28. Maddrey WC. Hepatic vein thrombosis (Budd-Chiari syndrome). Hepatology 1984; 4:44S.
  29. Nobre S, Khanna R, Bab N, et al. Primary Budd-Chiari Syndrome in Children: King's College Hospital Experience. J Pediatr Gastroenterol Nutr 2017; 65:93.